close

Book an open event

The postgraduate online event on the 17 June – 21 June 2024 is the perfect opportunity to find out more about your course of interest, speak with our academics, and discover the opportunities that further study has to offer.

Join us live to learn more about:

  • Your chosen course: Speak to our friendly teaching staff about courses, module content and delivery methods
  • Employment prospects: Understand work placement opportunities, industry connections, and course accreditations
  • Support services: Get all the information you need about admissions, accommodation and student finance
  • Life at Herts: Hear from our students about their postgrad student experience at Herts
close

Apply now

MSc Cancer Immunotherapy

Why choose Herts?

Teaching Excellence: You will be taught by Internationally renowned researchers who support with research projects in Cancer Immunotherapy.

Employment Prospects: Graduates work as research scientists, scientific officers, and senior managers for organisations including Roche, Merck, and Astra Zeneca.

Sector-led Course Content: Explore our research interests of the Bioscience Research Group covering topics such as Adoptive T cell therapy, tumour-associated macrophages, NK cells, and monoclonal antibodies in cancer therapy.

Professional Accreditations

Subject to validation, this course will be accredited by the Royal Society for Biology Accreditation.

About the course

The aim of the MSc in Cancer Immunotherapy is through an understanding of the numerous ways in which cancers and the immune system interact, to learn how cancer immunotherapies are developed. The utilisation of the immune system in cancer therapy has been a long standing goal in the field. The course will provide a thorough understanding of immune effector mechanisms and of cancer biology and the personal skills the students will develop, through problem-based learning and self-directed learning.

Alternatively, consider taking our other MSc Cancer Immunotherapy routes:

Why choose this course?

  • 1st for Biosciences in the Postgraduate Taught Experience Survey (PTES, Advance HE, 2023)
  • You’ll be taught by our expert staff and innovative speakers from the biopharmaceutical industry
  • Our modern Science Building provides excellent facilities for laboratory experiments, including DNA and genomic analysis eg QPCR, protein and proteomic science (eg MALDI-ToF), cell culture and Enzyme-based assays, isolated tissue studies and immunohistochemistry
  • When you graduate, you’ll be equipped to work in a broad range of fields including medical or pharmaceutical research and development, clinical trials, public health and epidemiology, academia research, medical writing and science journalism, education, or patent law
  • We adopt a blended learning approach to teaching, focussing on problem-based scenarios so you can develop strong critical analysis skills. You’ll benefit from exposure to practical techniques and guaranteed laboratory-based research projects

What will I study?

You’ll benefit from the research interests of the Bioscience Research Group. These include studies of the tumour microenvironment and communication with infiltrating immune cells, the methods tumours employ to diminish the effectivity of immune effector mechanisms and how tumours communicate using extracellular vesicles with pre-metastatic sites. We’ll cover topics such as adoptive T cell therapy, tumour-associated macrophages, NK cells, monoclonal antibodies in cancer therapy, vaccines, microbial cancer therapies and immune checkpoint blockade.

Teaching will be delivered through lectures, tutorials and practical classes. You’ll immerse yourself in a research project which utilises problem-based and self-directed learning. You’ll explore case studies to gain a strong critical understanding. Through your research projects, carried out in our innovative Science Building and supervised by world-leading researchers, you’ll be trained in data collection, analysis and its interpretation. You’ll also benefit from expert external speakers from the biopharmaceutical industry.

  • Level 7
    ModuleCreditsCompulsory/optional
    Translational Medical Science30 CreditsCompulsory
    Contemporary Topics in Cancer Immunotherapy30 CreditsCompulsory
    Molecular Medicine30 CreditsCompulsory
    Research Project with Research Methods60 CreditsCompulsory
    Molecular Cell Biology and Immunology30 CreditsCompulsory
  • Key staff

    Dr Madhu Goyal
    Programme Leader
    Find out more about Dr Madhu Goyal

    Dr Shoib Siddiqui
    Deputy Programme Leader

    Further course information

    Course fact sheets
    MSc Cancer Immunotherapy (Revised 2024) Download
    Programme specifications
    MSc Cancer Immunotherapy (Revised 2024) Download
    Additional information

    Sandwich placement or study abroad year

    n/a

    Applications open to international and EU students

    Yes

    Student experience

    At the University of Hertfordshire, we want to make sure your time studying with us is as stress-free and rewarding as possible. We offer a range of support services including; student wellbeing, academic support, accommodation and childcare to ensure that you make the most of your time at Herts and can focus on studying and having fun.

    Find out about how we support our students

    You can also read our student blogs to find out about life at Herts.